Global Policy Forum Chair, Dan Ollendorf (United States), 2020-22
Dr. Dan Ollendorf is Director of Value Measurement and Global Health Initiatives at the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts University. His research interests include expanding the use of health technology assessment in developing economies, as well as refinement of value assessment tools in the US and other developed settings. Prior to joining CEVR, he was Chief Scientific Officer for the Institute for Clinical and Economic Review (ICER) for over 10 years, where he was responsible for the conduct of assessments of the clinical effectiveness and economic value of high impact health care technologies as well as coordination of the broader HTA process. His 30 years of experience also include work in the hospital, informatics, insurance, and consulting sectors. Dr. Ollendorf holds a PhD in clinical epidemiology from the University of Amsterdam, a MPH from Boston University, and a BA from the University of Rochester. He currently serves on the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC), the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) HTA Council Working Group.
Editor in Chief, International of Technology Assessment in Health Care, Wendy Babidge (Australia)
Wendy Babidge is Director of the Research, Audit and Academic Surgery Division of the Royal Australasian College of Surgeons. This role was established in 2005 after the expansion of research and audit activities in the Division, following the establishment of the Australian Safety and Efficacy Register of New Interventional Procedures-Surgical (ASERNIP- S) in 1998.
Wendy has an Honours Degree in Biotechnology, a PhD from the University of Adelaide and a Graduate Diploma in Business. She is a Graduate of the Australian Institute of Company Directors, a Fellow of the Australian Institute of Management and an Associate Professor of the University of Adelaide.
Wendy is the past Chair of the International Network of Agencies for Health Technology Assessment (INAHTA) Board and, following several years as a Deputy Editor for the International Journal of Technology Assessment in Health Care was appointed as the Editor-in-Chief in 2016.
INAHTA Board Chair, Sophie Werkö (Sweden)
Sophie Werkö has an MSc in Business Administration, IBA, and a PhD from the University of Stockholm. She has a longstanding engagement with HTA and held the role as Project Director at The Swedish Council on Health Technology Assessment (SBU) including project management, systematic literature reviews and health technology assessment reports. In 2012 she was appointed Manager of International Relations at SBU, responsible for coordinating SBU’s international work.
Since 2010, Werkö has attended the annual meetings of INAHTA and is together with David Hailey chairing the working group on Impact. She is a member of the steering committee of the Health Technology Assessment International (HTAi) Interest Group on Patient and Citizens Involvement since 2007. She is also the chair of the HTAi subgroup on Patient Issues: Methods and Impact Working Group which she set up in 2011 together with Sophie Staniszewska and Javier Gracia San Roman and has managed the group since then. She has participated in The European network for Health Technology Assessment’s (EUnetHTA’s) Work Package 4 on the HTA Core Model (focusing on the core methodology of HTAs) since 2009 and she also had a seat in the EUnetHTA Executive Committee Joint Action 1. She has presented at many national and international conferences, with panel presentations at HTAi in Rio de Janeiro, Brazil (2011). She has several peer-reviewed publications in international and national journals and acts as a reviewer of manuscripts for several international journals.